SEARCH

SEARCH BY CITATION

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
hep26425-sup-0001-suppfig1.tif247KSupporting Figure 1. Time-dependent effect of sorafenib. Two days after Alexander cells were transfected with wild-type OCT1 or empty vector (Mock) they were exposed to 5 µM sorafenib for the indicated time. Cell viability was determined 72 h after adding the sorafenib to the culture media. Values are means±SD from 4 experiments performed in triplicate. *, p<0.05, as compared with wild-type OCT1.
hep26425-sup-0002-supptab1.doc61KSupporting Table 1. Patient and tumor information
hep26425-sup-0003-supptab2.doc45KSupporting Table 2. Oligonucleotide sequence of specific primers for wild-type OCT1 or its variants used in this study.
hep26425-sup-0004-supptab3.doc55KSupplementary Information
hep26425-sup-0005-supptab4.doc54KSupporting Table 4. Screening of genetic variants affecting the coding sequence of OCT1 in cholangiocarcinoma (CGC) biopsies.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.